Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 August 2024 | Story Anthony Mthembu | Photo Sibahle Dayimani and Amandla Kulu
Prof Peter Rosseel
Prof Peter Roseel, Managing Director of Management Consulting and Research – a spin-off of the Catholic University of Leuven in Belgium; and Prof Nicolene Barkhuizen, Director of the UFS Business School.

The Business School at the University of the Free State (UFS) hosted Prof Peter Rosseel, Managing Director of Management Consulting and Research – a spin-off of the Catholic University of Leuven in Belgium – for a guest lecture during his visit to the UFS Faculty of Economic and Management Sciences (EMS).

The guest lecture took place on 19 July 2024 in the Business School Auditorium and was attended by academics from the UFS.

Reflecting on the lecture

The lecture presented by Prof Rosseel focused on how combining strategy, strategy implementation, culture transformation, leadership, and learning successfully leads to sustainable growth, creates engagement, and delivers tangible results. Throughout the lecture, Prof Rosseel spoke about how experts tend to make bad leaders and therefore stop change from happening within an organisation. In fact, he highlighted that, “Experts stop change from happening within the workplace because experts, by definition, look through the eyes of their expertise, but you cannot reduce the world to different forms of expertise, as it is holistic.” As such, he argued that to change an organisation, one must see things from the point of view of others.

Furthermore, Prof Rosseel delved deeper into the hierarchical operating model within organisations. He indicated that the above model should be one community within organisations; however, unfortunately it is not. This is because organisations are made up of several departments such as finance and human resources. As such, he regards these departments to be silos that could prove to be detrimental to organisations, as each silo can create its own culture as opposed to an organisational culture. These are some of the points he discussed throughout the lecture.

After the lecture concluded, the audience had the opportunity to engage with Prof Rosseel on his viewpoints. In fact, Lyle Markham, Academic Head of Department and Lecturer in Industrial Psychology at the UFS, was one of the audience members and described the lecture as insightful.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept